The second affiliated hospital of Zhejiang University
Hangzhou, Zhejiang, 310000, China
NCT Number: NCT03317639
A cluster randomised controlled trial will be conducted, using hospital as randomisation unit. Hospitals in Zhejiang Province, China, will be randomised into two arms (1:1): an intervention arm and a control arm. Hospitals in the intervention arm will receive a multi-components intervention based on the Behaviour Change Wheel model, whereas hospitals in the control arm will receive no intervention and maintain existing care. The randomisation will be conducted after one-year baseline data collection. The following baseline data will be used for randomisation match: hospital classification, beds in stroke centre, thrombolysis patient number, and percentage of patients receiving thrombolysis within 60 minutes of stroke onset. Hospitals with no stroke centre or with <20 cases received thrombolysis per year will be excluded from the study. The primary outcome will be difference between intervention arm and control arm in the percentage of patients receiving thrombolysis within 60 minutes of stroke onset on the follow-up stage (post-intervention).
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Hangzhou, Zhejiang, 310000, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Interventions are developed on a psychological model, the Behaviour Change Wheel (BCW) .The fundamental of BCW consists of three essential elements: capability, motivation, and opportunity. Improving individual's capability, providing motivation, and increasing opportunities are goals of behaviour change intervention. To achieve the goals, 9 intervention components have been proposed in the BCW framework, and 6 components will be used in current study.
Time frame: Up to 24 hours
Difference between intervention arm and control arm in the percentage of patients receiving thrombolysis within 60 minutes of stroke onset on the follow-up stage
Time frame: Up to 24 hours
The time between hospital arrival and the initiation of IVT
Time frame: Up to 24 hours
The time between the symptom onset and the initiation of IVT
Time frame: Up to 3 month
modified Rankin Scale score at discharge, on which scores range from 0 (no neurologic deficit) to 6 (death)
Time frame: At 24 hours
Intracranial hemorrhage at 24 hours associated with an increase of ≥4 points of NIHSS score from baseline, according to European Cooperative Acute Stroke Study (ECASS) II trial
Time frame: At 90 days
Score of 0 to 1 on the modified Rankin Scale, on which scores range from 0 (no neurologic deficit) to 6 (death)
Time frame: Up to 3 month
Death at discharge
Second Affiliated Hospital, School of Medicine, Zhejiang University
Other
Improving In-hospital Stroke Service Utilisation (MISSION) in China: A Cluster Randomised Trial of Interventions to Shorten Door to Needle Times
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03621917
Acute Stroke, Brain Diseases
Izmir, Narlidere, Turkey (Türkiye)
View Trial DetailsNCT04309357
Alteplase, Brain Diseases
Sari, Iran
View Trial DetailsNCT07018167
Brain Diseases, Brain Infarction
Gonesse, France
View Trial DetailsNCT07374978
Pulmonary Embolism Subacute Massive, Thrombolytic Therapy
Cairo, Abbassia, Egypt
View Trial Details